Evidence map›Paper›PMID 33082392›Full record

ArticleScientific reports2020

Toxic oligomers of the amyloidogenic HypF-N protein form pores in mitochondrial membranes.

Maria Ylenia Farrugia, Mario Caruana, Stephanie Ghio, Angelique Camilleri, Claude Farrugia, Ruben J Cauchi, Sara Cappelli, Fabrizio Chiti, Neville Vassallo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in neuroscience · 2022
    Review
  4. Amyloid pores in mitochondrial membranes.Neural regeneration research · 2021
    Article
  5. Article
  6. Review
  7. Extract from the Marine SeaweedMolecules (Basel, Switzerland) · 2021
    Article
  8. Review
  9. Membrane Interactions and Toxicity by Misfolded Protein Oligomers.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Maria Ylenia FarrugiaDepartment of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
Mario CaruanaCentre for Molecular Medicine and Biobanking, University of Malta, Msida, Malta.
Stephanie GhioDepartment of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
Angelique CamilleriDepartment of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
Claude FarrugiaDepartment of Chemistry, University of Malta, Msida, Malta.
Ruben J CauchiDepartment of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
Sara CappelliSection of Biochemistry, Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134, Florence, Italy.
Fabrizio ChitiSection of Biochemistry, Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134, Florence, Italy.
Neville VassalloDepartment of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta. neville.vassallo@um.edu.mt.
University of Malta · MTUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies on the amyloidogenic N-terminal domain of the E. coli HypF protein (HypF-N) have contributed significantly to a detailed understanding of the pathogenic mechanisms in neurodegenerative diseases characterised by the formation of misfolded oligomers, by proteins such as amyloid-β, α-synuclein and tau. Given that both cell membranes and mitochondria are increasingly recognised as key targets of oligomer toxicity, we investigated the damaging effects of aggregates of HypF-N on mitochondrial membranes. Essentially, we found that HypF-N oligomers characterised by high surface hydrophobicity (type A) were able to trigger a robust permeabilisation of mito-mimetic liposomes possessing cardiolipin-rich membranes and dysfunction of isolated mitochondria, as demonstrated by a combination of mitochondrial shrinking, lowering of mitochondrial membrane potential and cytochrome c release. Furthermore, using single-channel electrophysiology recordings we obtained evidence that the type A aggregates induced currents reflecting formation of ion-conducting pores in mito-mimetic planar phospholipid bilayers, with multi-level conductances ranging in the hundreds of pS at negative membrane voltages. Conversely, HypF-N oligomers with low surface hydrophobicity (type B) could not permeabilise or porate mitochondrial membranes. These results suggest an inherent toxicity of membrane-active aggregates of amyloid-forming proteins to mitochondria, and that targeting of oligomer-mitochondrial membrane interactions might therefore afford protection against such damage.

Indexed as

alpha-SynucleinAmyloidAmyloid beta-PeptidesCarboxyl and Carbamoyl TransferasesCardiolipinsEscherichia coliEscherichia coli ProteinsHumansHydrophobic and Hydrophilic InteractionsLipid BilayersMembrane Potential, MitochondrialMitochondriaMitochondrial MembranesNeurodegenerative DiseasesProtein ConformationProtein Multimerizationalpha-SynucleinAmyloidAmyloid beta-PeptidesCarboxyl and Carbamoyl TransferasesCardiolipinsEscherichia coli ProteinshypF protein, E coliLipid Bilayerstau Proteins

Identifiers

PMID33082392
PMCPMC7575562
OpenAlexW3093586095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.